A detailed history of True Wealth Design, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, True Wealth Design, LLC holds 115 shares of NVCR stock, worth $2,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Holding current value
$2,202
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$14.54 - $33.41 $1,672 - $3,842
115 New
115 $3.43 Million
Q4 2022

Feb 15, 2023

BUY
$63.98 - $85.37 $63 - $85
1 New
1 $73,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.01B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.